Firstly, growth factor signalling is known to regulate ERα expression through unclear mechanisms; the transcription factor AP2Υ is known to be important in regulating ERα expression and the levels of AP2Υ are elevated in breast cancer as compared to normal breast (Turner et al, 1998). The gene discussed is ESR1; the disease is breast carcinoma.